05/01/2020: Lab Advisory: CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing
Audience: Clinical Laboratory Professionals
Level: Laboratory Advisory
CMS Issues Additional Guidance on SARS-CoV-2 Laboratory Testing
On April 30, 2020, the Centers for Medicare & Medicaid Services (CMS) released additional guidance to clarify:
- The types of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests that are available, and whether or not they have received emergency use authorization by FDA
- The Clinical Laboratory Improvement Amendments (CLIA) certifications under which each test can be performed
- An explanation of requirements under each testing scenario
- Information for Medicare beneficiaries on testing services and coverage
Online Resources:
Laboratory Outreach Communication System | Division of Laboratory Systems (DLS)
Center for Surveillance, Epidemiology, and Laboratory Services (CSELS)
Centers for Disease Control and Prevention (CDC)